Pesquisa | Biblioteca Virtual em Saúde

1.

Parsaclisib, a potent and highly selective PI3KÎ´ inhibitor, in patients with relapsed or refractory B-cell malignancies.

Forero-Torres, Andres; Ramchandren, Radhakrishnan; Yacoub, Abdulraheem; Wertheim, Michael S; Edenfield, William J; Caimi, Paolo; Gutierrez, Martin; Akard, Luke; Escobar, Carolina; Call, Justin; Persky, Daniel; Iyer, Swaminathan; DeMarini, Douglas J; Zhou, Li; Chen, Xuejun; Dawkins, Fitzroy; Phillips, Tycel J.

Blood ; 133(16): 1742-1752, 2019 04 18.

Artigo em Inglês | MEDLINE | ID: mdl-30803990

2.

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.

Maertens, Johan; Logan, Aaron C; Jang, Junho; Long, Gwynn; Tang, Jih-Luh; Hwang, William Y K; Koh, Liang Piu; Chemaly, Roy; Gerbitz, Armin; Winkler, Julia; Yeh, Su-Peng; Hiemenz, John; Christoph, Sandra; Lee, Dong-Gun; Wang, Po-Nan; Holler, Ernst; Mielke, Stephan; Akard, Luke; Yeo, Adeline; Ramachandra, Sangana; Smith, Kristin; Pertel, Peter; Segal, Florencia.

Antimicrob Agents Chemother ; 64(4)2020 03 24.

Artigo em Inglês | MEDLINE | ID: mdl-32015031

3.

Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model.

LeMaistre, Charles F; Wacker, Kara K; Akard, Luke P; Al-Homsi, A Samer; Gastineau, Dennis A; Godder, Kamar; Lill, Michael; Selby, George B; Steinberg, Amir; Anderson, Judy M; Leahigh, Alan K; Warkentin, Phyllis I.

Biol Blood Marrow Transplant ; 25(11): 2243-2250, 2019 11.

Artigo em Inglês | MEDLINE | ID: mdl-31284070

4.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher, Michael A; Logan, Brent R; Chitphakdithai, Pintip; Kiefer, Deidre M; Riches, Marcie L; Rizzo, J Douglas; Anderlini, Paolo; Leitman, Susan F; Varni, James W; Kobusingye, Hati; Besser, RaeAnne M; Miller, John P; Drexler, Rebecca J; Abdel-Mageed, Aly; Ahmed, Ibrahim A; Akard, Luke P; Artz, Andrew S; Ball, Edward D; Bayer, Ruthee-Lu; Bigelow, Carolyn; Bolwell, Brian J; Broun, E Randolph; Bunin, Nancy J; Delgado, David C; Duckworth, Katharine; Dvorak, Christopher C; Hahn, Theresa E; Haight, Ann E; Hari, Parameswaran N; Hayes-Lattin, Brandon M; Jacobsohn, David A; Jakubowski, Ann A; Kasow, Kimberly A; Lazarus, Hillard M; Liesveld, Jane L; Linenberger, Michael; Litzow, Mark R; Longo, Walter; Magalhaes-Silverman, Margarida; McCarty, John M; McGuirk, Joseph P; Mori, Shahram; Prasad, Vinod K; Rowley, Scott D; Rybka, Witold B; Sahdev, Indira; Schriber, Jeffrey R; Selby, George B; Shaughnessy, Paul J; Shenoy, Shalini.

Biol Blood Marrow Transplant ; 25(4): 699-711, 2019 04.

Artigo em Inglês | MEDLINE | ID: mdl-30423480

5.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Pulsipher, Michael A; Logan, Brent R; Kiefer, Deidre M; Chitphakdithai, Pintip; Riches, Marcie L; Rizzo, J Douglas; Anderlini, Paolo; Leitman, O'Susan F; Kobusingye, Hati; Besser, RaeAnne M; Miller, John P; Drexler, Rebecca J; Abdel-Mageed, Aly; Ahmed, Ibrahim A; Akard, Luke P; Artz, Andrew S; Ball, Edward D; Bayer, Ruthee-Lu; Bigelow, Carolyn; Bolwell, Brian J; Broun, E Randolph; Delgado, David C; Duckworth, Katharine; Dvorak, Christopher C; Hahn, Theresa E; Haight, Ann E; Hari, Parameswaran N; Hayes-Lattin, Brandon M; Jacobsohn, David A; Jakubowski, Ann A; Kasow, Kimberly A; Lazarus, Hillard M; Liesveld, Jane L; Linenberger, Michael; Litzow, Mark R; Longo, Walter; Magalhaes-Silverman, Margarida; McCarty, John M; McGuirk, Joseph P; Mori, Shahram; Parameswaran, Vinod; Prasad, Vinod K; Rowley, Scott D; Rybka, Witold B; Sahdev, Indira; Schriber, Jeffrey R; Selby, George B; Shaughnessy, Paul J; Shenoy, Shalini; Spitzer, Thomas.

Haematologica ; 104(4): 844-854, 2019 04.

Artigo em Inglês | MEDLINE | ID: mdl-30381298

6.

Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained.

Caldemeyer, Lauren E; Akard, Luke P; Edwards, John R; Tandra, Anand; Wagenknecht, Dawn R; Dugan, Michael J.

Biol Blood Marrow Transplant ; 23(11): 1989-1997, 2017 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-28712934

7.

Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic- or accelerated-phase chronic myeloid leukemia: Results with 24 months of follow-up.

Cortes, Jorge E; Kantarjian, Hagop M; Rea, Delphine; Wetzler, Meir; Lipton, Jeffrey H; Akard, Luke; Khoury, H Jean; Michallet, Mauricette; Guerci-Bresler, Agnès; Chuah, Charles; Hellmann, Andrzej; Digumarti, Raghunadharao; Parikh, Purvish M; Legros, Laurence; Warzocha, Krzysztof; Baccarani, Michele; Li, Elizabeth; Munteanu, Mihaela; Nicolini, Franck E.

Cancer ; 121(10): 1637-44, 2015 May 15.

Artigo em Inglês | MEDLINE | ID: mdl-25586015

8.

Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.

Sharma, Akshay; Logan, Brent; Estrada-Merly, Noel; Lehmann, Leslie E; Rangarajan, Hemalatha G; Preussler, Jaime M; Troy, Jesse D; Akard, Luke P; Bhatt, Neel S; Truong, Tony H; Wood, William A; Strouse, Christopher; Juckett, Mark; Khera, Nandita; Rizzo, Douglas; Saber, Wael.

Transplant Cell Ther ; 29(8): 523-528, 2023 08.

Artigo em Inglês | MEDLINE | ID: mdl-37220838

9.

Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemia.

Jabbour, Elias J; Bixby, Dale; Akard, Luke P.

Clin Adv Hematol Oncol ; 10(12 Suppl 22): 1-16, 2012 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-23271195

10.

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.

Desai, Pinkal M; Brown, Janice; Gill, Saar; Solh, Melham M; Akard, Luke P; Hsu, Jack W; Ustun, Celalettin; Andreadis, Charalambos; Frankfurt, Olga; Foran, James M; Lister, John; Schiller, Gary J; Wieduwilt, Matthew J; Pagel, John M; Stiff, Patrick J; Liu, Delong; Khan, Irum; Stock, Wendy; Kambhampati, Suman; Tallman, Martin S; Morris, Lawrence; Edwards, John; Pusic, Iskra; Kantarjian, Hagop M; Mamelok, Richard; Wong, Alicia; Van Syoc, Rodney; Kellerman, Lois; Panuganti, Swapna; Mandalam, Ramkumar; Abboud, Camille N; Ravandi, Farhad.

J Clin Oncol ; 39(29): 3261-3272, 2021 10 10.

Artigo em Inglês | MEDLINE | ID: mdl-34156898

11.

Eltrombopag in refractory aplastic anemia.

Akard, Luke.

N Engl J Med ; 367(12): 1162-3; author reply 1163, 2012 09 20.

Artigo em Inglês | MEDLINE | ID: mdl-22992085

12.

Transportation of peripheral blood progenitor cell products: effect of ambient temperature.

Jansen, Jan; Nolan, Pamela L; Reeves, Margaret I; Morgan, Jeffrey A; Akard, Luke P; Thompson, James M; Dugan, Michael J; Hanks, Susan G.

Cytotherapy ; 12(7): 919-23, 2010 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-20429789

13.

Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration.

Jansen, Jan; Nolan, Pamela L; Reeves, Margaret I; Akard, Luke P; Thompson, James M; Dugan, Michael J; Hanks, Susan G.

Cytotherapy ; 11(1): 79-85, 2009.

Artigo em Inglês | MEDLINE | ID: mdl-19153854

14.

Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster engraftment without increased resource utilization.

Thompson, James M; Carlton, Pam; Akard, Luke P; Dugan, Michael J; Jansen, Jan.

Transfusion ; 49(3): 548-54, 2009 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-19040494

15.

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.

Ciurea, Stefan O; Sadegi, Barry; Wilbur, Andrew; Alagiozian-Angelova, Victoria; Gaitonde, Sujata; Dobogai, Lisa C; Akard, Luke P; Hoffman, Ronald; Rondelli, Damiano.

Br J Haematol ; 141(1): 80-3, 2008 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-18324970

16.

Second-generation BCR-ABL kinase inhibitors in CML.

Akard, Luke P.

N Engl J Med ; 363(17): 1672-3; author reply 1673-5, 2010 10 21.

Artigo em Inglês | MEDLINE | ID: mdl-20973144

17.

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors.

Nicolini, Franck E; Khoury, H Jean; Akard, Luke; Rea, Delphine; Kantarjian, Hagop; Baccarani, Michele; Leonoudakis, Janis; Craig, Adam; Benichou, Annie-Claude; Cortes, Jorge.

Haematologica ; 98(7): e78-9, 2013 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-23753022

18.

Improving Outcomes in Chronic Myeloid Leukemia Over Time in the Era of Tyrosine Kinase Inhibitors.

Chopade, Pradnya; Akard, Luke P.

Clin Lymphoma Myeloma Leuk ; 18(11): 710-723, 2018 11.

Artigo em Inglês | MEDLINE | ID: mdl-30093283

19.

Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib.

Ailawadhi, Sikander; Akard, Luke P; Miller, Carole B; Jillella, Anand; DeAngelo, Daniel J; Ericson, Solveig G; Lin, Felice; Warsi, Ghulam; Radich, Jerald.

Ther Adv Hematol ; 8(1): 3-12, 2017 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-28042454

20.

Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase.

Akard, Luke P; Bixby, Dale.

Leuk Lymphoma ; 57(5): 1002-14, 2016 May.

Artigo em Inglês | MEDLINE | ID: mdl-26726949

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar: